STOCK TITAN

Illumina Inc - ILMN STOCK NEWS

Welcome to our dedicated news page for Illumina (Ticker: ILMN), a resource for investors and traders seeking the latest updates and insights on Illumina.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Illumina's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Illumina's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.38%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.94%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.94%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.6%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.43%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.88%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.59%
Tags
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.88%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.19%
Tags
none
Illumina Inc

Nasdaq:ILMN

ILMN Rankings

ILMN Stock Data

20.24B
158.41M
0.24%
94.5%
3.32%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
US
San Diego

About ILMN

at illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. these studies will help make the realization of personalized medicine possible. with such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. as a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. illumina’s innovative, array-based solutions for dna, rna, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.